Cilfa Opposition, Oprozomib, (Ar110374 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, brigatinib, (AR111169A1)
Countries: Argentina Date: 2019
-
CILFA opposition, amino acids, (AR110548A1)
Countries: Argentina Date: 2019
-
CILFA opposition, osimertinib, (AR115019A2)
Countries: Argentina Date: 2021
-
CILFA opposition, cannabinoid, (AR113749A1)
Countries: Argentina Date: 2020
-
CILFA opposition, vinorelbine, (AR107829A1)
Countries: Argentina Date: 2018
-
CILFA opposition, LSD1 inhibitor, (AR107871A1)
Countries: Argentina Date: 2018
-
CILFA opposition, PI3K delta INHIBITORS, (AR100619A1)
Countries: Argentina Date: 2017
-
CILFA opposition, botulinum toxin A, (AR112121A1)
Countries: Argentina Date: 2019
-
CILFA opposition, dapagliflozin-empagliflozin-insulin, (AR112015A1)
Countries: Argentina Date: 2019
-
CILFA opposition, cariprazine, (AR112137A1)
Countries: Argentina Date: 2019